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Alkaloids account for some of the most beautiful and biologically active natural products. Although they are
usually classified along biosynthetic criteria, they can also be categorized according to certain structural
motifs. Amongst these, the a-tertiary amine (ATA), i.e. a tetrasubstituted carbon atom surrounded by
three carbons and one nitrogen, is particularly interesting. A limited number of methods have been
described to access this functional group and fewer still are commonly used in synthesis. Herein, we
review some approaches to asymmetrically access ATAs and provide an overview of alkaloid total
syntheses where those have been employed.1 Introduction
2 Methods used for the installation of a-tertiary amines
2.1 A C,C-bond is formed in the step that generates the ATA









11 Indolizidine and quinolizidine alkaloids






18 Notes and references1 Introduction
Alkaloids have played an important role in the development of
synthetic organic chemistry, pharmacology and medicine. Once
considered to be metabolic waste products, they are now known to
benet their producers in various ways, e.g. as antimicrobials,g-Maximilians-Universität München, and
cience, Butenandtstr. 5 – 13, 81377
lmu.de
review.
hemistry 2016antifeedants or asmediators of ecologically benecial interactions.1
Though a limited number of amino acids are involved in their
biosynthesis, alkaloids exhibit enormous structural variability,
which is oen increased through the incorporation of terpenoid
and polyketide components and late-stage oxidative trans-
formations.2Reecting their structural diversity and relatively weak
basicity, alkaloids interact with a large variety of biological targets
and have foundmany uses in humanmedicine.3,4 In addition, they
have provided inspiration for countless synthetic drugs that borrow
structural motifs from their natural counterparts.
The a-tertiary amine (ATA) stands out among the structural
features frequently found in alkaloids.5–8 For the purposes ofFig. 1 Alkaloids and synthetic molecules that contain the ATA motif.
Nat. Prod. Rep., 2016, 33, 491–522 | 491
























































































View Article Onlinethis review and in keeping with the literature, we dene an ATA
as a nitrogen atom bound to a sp3-hybridized carbon that bears
three additional carbon–carbon bonds. The nitrogen itself can
be sp3-hybridized as part of a primary, secondary and tertiary
amine. Broadening our denition, it can also be sp2- or sp-
hybridized, e.g. in an amide or isonitrile. The tetrasubstituted
carbon from which the C,N-bond branches out is oen stereo-
genic, which makes ATAs particularly interesting from
a synthetic point of view. Our denition puts emphasis on this
particular C,N-bond and avoids the confusion that is oen
associated with the term ‘quaternary stereocenter’, which,
strictly speaking, refers only to a carbon atom surrounded by
four other carbons.
Fig. 1 shows some alkaloids and drugs with alkaloid-like
properties that illustrate our denition and demonstrate that the
nitrogen in ATAs (highlighted in red) can be substituted to
various degrees. Memantine and huperzine A contain primary
ATAs, whereas ketamine,MK-801 and histrionicotoxin 283A (HTXNina Vrielink was born in 1987
in Nordhorn, Germany. She
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ter's studies in chemistry in
Munich, she joined the group of
Prof. E. Tate at the Imperial
College London for a research
internship. In 2012, she joined
the laboratory of Prof. D. Trau-
ner for her Master's thesis and
returned to conduct her Ph.D.
studies starting in 2013. In
2014, she visited the laboratory of Prof. B. M. Stoltz for three
months. She is currently pursuing natural product synthesis of a-
tertiary-amine-containing alkaloids, supported by a scholarship
from the Deutsche Telekom Foundation.
Anastasia Hager studied chem-
istry in Würzburg, conducting
her Diploma thesis on natural
product isolation and synthesis
with Prof. G. Bringmann. Aer
joining Prof. D. Trauner's
research group for an internship
at UC Berkeley, she moved to
Munich for her PhD work that
was centered on the develop-
ment of biomimetic syntheses of
complex natural products
implementing cascade reactions.
From 2013 until 2015 she was a postdoctoral fellow with Prof. D.
Fiedler at Princeton University developing novel chemical tools to
allow for investigations of inositol pyrophosphate signaling
pathway. She now works as a laboratory head in process research
at Bayer in Wuppertal.
492 | Nat. Prod. Rep., 2016, 33, 491–522283A) feature secondary ATAs, and lycopodine is representative of
molecules containing a tertiary ATA. 2,2,6,6-Tetramethylpiper-
idine (TMP) and the alkaloid porantherine are examples for
molecules featuring a twofold ATA. The dimeric alkaloid ste-
phacidin B contains no fewer than four ATAs. Notably, the a-
carbons are stereogenic in the majority of these compounds.
In this review, we wish to provide a brief survey of synthetic
methods used to install the ATA motif and discuss their appli-
cation in the total synthesis of alkaloids. The syntheses included
here have been selected based on their historical signicance,
the intriguing structure of their target molecule, and the
elegance and efficiency of the method used. The order of their
presentation is somewhat arbitrary, mixing biosynthetic and
taxonomic categories (such as Lycopodium alkaloids), with purely
structural ones (such as quinolizidine alkaloids). Generally, we
have aimed to proceed from simpler target molecules to more
complex ones. While our review is by no means comprehensive,
we hope to feature the most instructive examples for theJulien Lefranc was born in 1984
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View Article Onlineestablishment of ATAs and thus provide inspiration and valu-
able lessons for future work. We also hope that this review will
benet the design of synthetic pathways toward drugs and
synthetic building blocks that contain a-tertiary amines.Scheme 1 C,C-bond formation involving electrophilic a-carbons.2 Methods used for the installation of
a-tertiary amines
Many approaches toward the installation of ATAs have been
developed but only a relatively small subset of these has proven
popular in alkaloid total synthesis. Here, we provide a brief
survey of these methods, discussing them in general terms. We
classify them according to the bond that is formed in the key
step and the electronic nature of the nitrogen and carbon,
respectively. However, it should be noted that not all of the
syntheses discussed in this review fall into this simplied
organizational scheme.2.1 A C,C-bond is formed in the step that generates the ATA
 The a-carbon is electrophilic. Some of the most commonly
encountered methods involve the addition of carbon nucleo-
philes to activated imines and iminium ions (Scheme 1). They
include Mannich reactions, Strecker reactions, aza-Prins reac-
tions and the 1,2-addition of organometallic reagents to C,N-
double bonds. N-Acyliminium ions are particularly powerful
electrophiles in reactions of this type. A variant of the Heck
olenation that involves enamines also falls into this category.
 The a-carbon is nucleophilic. In an Umpolung of the above
situation, the a-carbon can also serve as a nucleophile (Scheme
2). For instance, the alkylation of branched nitroalkanes or of
deprotonated amino acid derivatives can be used to establish
ATAs. Insertions of carbons into nucleophilic C,H-bonds next to
a C,N-bond are a member of this general category as well.
 Pericyclic reactions. Pericyclic reactions that form a C,C-
bond in the key step have occasionally been employed to formDirk Trauner was born and grew
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This journal is © The Royal Society of Chemistry 2016ATAs (Scheme 3). They include Diels–Alder cycloadditions
involving 1-aminodienes or 2-azadienes, as well as certain
amino dienophiles, [2+2] cycloadditions, and 1,3-dipolar
cycloadditions involving nitrones and azomethine imines.
 Radical reactions. Radical reactions establishing ATAs are
relatively rare, but not unprecedented (Scheme 4). 5-endo-Trig
and 6-endo-trig cyclizations as well as radical transfer allylations
belong to this category.2.2 A C,N-bond is formed in the step that generates the ATA
 The nitrogen is electrophilic. Rearrangements that involve
electron-decient nitrogen atoms are oen encountered in the
formation of ATAs (Scheme 5).
They include the Curtius, Schmidt, Hofmann, Beckmann
and Stieglitz rearrangements.5 Oen, these reactions can be
classied as [1,2] sigmatropic rearrangements. RelatedScheme 2 C,C-bond formation involving nucleophilic a-carbons.
Scheme 3 C,C-bond formation involving pericyclic reactions.
Nat. Prod. Rep., 2016, 33, 491–522 | 493
Scheme 4 C,C-bond formation via radical reactions.
Scheme 6 C,N-bond formation involving nucleophilic nitrogens.
EWG ¼ electron-withdrawing group.
























































































View Article Onlinenucleophilic substitutions involving N-haloamines have been
used as well. An electron-decient nitrogen atom also plays
a role in the insertion of nitrenes into C,H-bonds.
 The nitrogen is nucleophilic. The formation of ATAs through
nucleophilic additions or substitutions involving nitrogen is
fairly common (Scheme 6). The classical Michael addition falls
into this category, as do SN20 reactions and haloaminations. For
obvious reasons, SN2 reactions are rare and mostly conned to
intramolecular cases. Carbocations that react with a nucleo-
philic nitrogen occur in the aza-Prins reaction and the Ritter
reaction. Oxidative dearomatizations have also been used in
a few cases to establish ATAs.
 Pericyclic reactions. Pericyclic reactions in which a C,N-
bond is formed provide powerful means to establish ATAs
(Scheme 7). Overman, Kazmaier–Claisen and [3,3] sigmatropic
rearrangements of allylic isocyanides belong to this category.
Divinyl cyclopropane rearrangements have also been used to
establish ATAs.5Scheme 5 C,N-bond formation involving electrophilic nitrogens.
Scheme 7 C,N-bond formation involving pericyclic reactions.
494 | Nat. Prod. Rep., 2016, 33, 491–522Many more methods have emerged in recent years that can
be used to create ATAs, such as reactions proceeding via C,H-
activation9 and hydroaminations.10 Since they have not yet been
employed in the total synthesis of alkaloids, they are not
featured in this review. Other methods, such as the Mannich
reaction, Curtius rearrangement and Michael reaction, have
proven to be so popular in the total synthesis of alkaloids that
we cannot include all instances where they have been employed
in this review.3 Homotropane alkaloids
One of the rst applications of Mannich reactions in the
construction of ATAs occurred during the synthesis of certain
homotropane alkaloids. Three representatives, euphococcinine,
N-methyl euphococcine and adaline, feature an ATA in the
bridgehead position of a bicyclic framework (Fig. 2). These
simple natural products are excreted by lady beetles (cocci-
nellids) when threatened.11,12This journal is © The Royal Society of Chemistry 2016
Fig. 2 Representative ATA-containing homotropane alkaloids.
Scheme 8 Homotropane alkaloid syntheses by Alder (1959) and Davis
(2010). Ac ¼ acetyl.
Fig. 3 The major members of the histrionicotoxin family.
























































































View Article OnlineIn 1959, Alder synthesized N-methyl-euphococcinine using
a protocol analogous to the famous tropinone syntheses of
Robinson13,14 and Schöpf15 (Scheme 8a).16 Dehydropyrane 1 was
converted into ketoaldehyde 2, which was then transformed
into N-methyl-euphococcinine in a one-pot process (via imi-
nium-intermediate 3).17–19 A similar strategy was later adopted
to synthesize the structurally related alkaloid adaline.20
Throughout the years, this biomimetic Mannich strategy was
adopted in other syntheses of euphococcinine and adaline.21–23
Alternative approaches involved a 1,3-dipolar cycloaddition,24
addition to an N-acyliminium ion,25 Michael addition26,27 and
allylic rearrangement of a cyanate to an isocyanate.28,29
In 2010, Davis published a biomimetic synthesis of
()-euphococcinine and ()-adaline in enantiopure form
(Scheme 8b).30 The key steps of these syntheses involved the
stereoselective formation of piperideine 6 and 7 from the
enantiomerically pure N-sulnyl aminoketones 4 and 5,
respectively.31 An ensuing intramolecular Mannich reaction
afforded the azabicyclononane natural products.Scheme 9 Early synthetic approaches to HTXs by Kishi (1975) and
Corey (1975). CSA ¼ camphorsulfonic acid, HTX ¼ histrionicotoxin, p-
TsCl ¼ para-toluenesulfonyl chloride.4 Histrionicotoxins
In 1971, Daly isolated six different alkaloids, termed histri-
onicotoxins (HTXs), from skin extracts of the Colombian poison
arrow frog Dendrobates histrionicus (Fig. 3).32,33 They all contain
a unique spirocyclic piperidine core and differ mostly in the
length and the degree of saturation of the two side chains.
Several histrionicotoxins were identied as inhibitors of nico-
tinic acetylcholine receptors,34–38 which, together with their
attractive structures, prompted signicant attention from the
synthetic community.39 The low natural abundance of theseThis journal is © The Royal Society of Chemistry 2016alkaloids and the fact that the frogs do not secrete HTXs in
captivity made an efficient synthetic approach all the more
desirable.
The rst total synthesis of histrionicotoxin alkaloids was
reported by Kishi in 1975 (Scheme 9a).40–42 His synthesis of
octahydrohistrionicotoxin (oHTX) utilized an intramolecular
acid-catalyzed aza-Michael addition to set the ATA. Amide 8 was
converted to a 2 : 1 mixture of epimeric spiroketolactams 9 and
10. It was possible to transform 9 into the desired diastereo-
isomer 10 upon treatment with sodium methoxide.
In the same year, Corey reported the rst racemic synthesis
of perhydrohistrionicotoxin (pHTX), a synthetic HTX derivative
(Scheme 9b).43 For the installation of the ATA, Corey used
a Beckmann rearrangement that expanded spirocyclic oxime 11
to spirocyclic amide 12. Several other groups subsequently
employed related ring expansion strategies.44–48
Stork reported a synthesis of HTX 283A using a Hofmann
rearrangement to set the ATA (Scheme 10a).49 During this
transformation, amide 13 was oxidized with bis(tri-
uoroacetoxy)iodobenzene to promote the alkyl migration,
giving amine 14 aer decarboxylation. More recently, Fukuyama
reported an asymmetric synthesis of HTX 283A (Scheme
10b).50,51 The key carboxylic acid 15 underwent a stereospecic
Curtius rearrangement to yield bicyclo[5.4.0]undecane 16,
which could be converted into HTX 283A.Nat. Prod. Rep., 2016, 33, 491–522 | 495
Scheme 10 HTX 283A syntheses by Stork (1990) and Fukuyama (2011).
HTX¼ histrionicotoxin, Ac¼ acetyl, Boc¼ tert-butyloxycarbonyl, t-Bu
¼ tert-butyl, DPPA ¼ diphenylphosphoryl azide, MOM ¼ methoxy-
methyl, PIFA ¼ (bis(trifluoroacetoxy)iodo)benzene.
Scheme 11 HTX 283A synthesis by Stockman and Fuchs (2006). HTX
¼ histrionicotoxin.
























































































View Article OnlineA particularly short and efficient synthesis of racemic HTX
283A was reported in 2006 by Stockman and Fuchs (Scheme
11).52 In their approach, the key intermediate 21 was formed
from the symmetric ketodinitrile 17 using a cascade reaction.
Ketone 17 was condensed with hydroxylamine yielding nitrone
18 aer intramolecular Michael addition. Subsequent intra-
molecular [3+2] cycloaddition afforded isoxazolidine 19.
Following its isolation, 19 was converted to its more stable
regioisomer 21 through a retro-[3+2]/[3+2] cycloaddition process
(via intermediate 20). This so-called ‘Holmes dinitrile’ (21) had
been previously converted into HTX 283A.53,54
Additional strategies to set the ATA in the histrionicotoxins
involved Michael reactions,41,55,56 Tsuji–Trost amination,57,58
iodoetherication,59–61 oxidative dearomatizations,62 Henry
reactions,63 diastereoselective aziridation,64 1,2-carbon migra-
tion of hydroxyimines,65 [2,3] sigmatropic rearrangements,66
[3,3] sigmatropic rearrangements (Kazmaier–Claisen rear-
rangement)67 and [2+2] cycloadditions.68,69496 | Nat. Prod. Rep., 2016, 33, 491–5225 Lycopodium alkaloids
The genus Lycopodium comprises more than 200 species of
moss-like plants that have been used in traditional Chinese
medicine for centuries.70 They have yielded a variety of ATA-
containing alkaloids, some of which are featured in Fig. 4.
Lycopodine, the rst member of the family described in the
literature,71 has proven to be a particularly attractive target for
chemical synthesis. In 1968, only seven years aer its structural
elucidation, Stork72 and Ayer73,74 simultaneously published the
rst syntheses of this natural product. Ayer established the ATA
using an intermolecular addition of a racemic Grignard reagent
to tricyclic, Cv-symmetric iminium ion 22 to obtain 23
(Scheme 12a).
Stork's synthesis involved a Pictet–Spengler type reaction,
furnishing tetracyclic amide 25 (24 / 25, Scheme 12b). A
similar cyclization approach was also utilized almost 30 years
later in Padwa's asymmetric synthesis of lycopodine (not
shown).75 Wiesner published a synthesis of 12-epi-lycopodine
and annotinine using an innovative photochemical strategy
(Scheme 12c).76–79 This work involved the conversion of vinyl-
ogous imide 26 into exo-methylene cyclobutane 27 via a photo-
chemical [2+2] cycloaddition of allene.
Heathcock established one of the most elegant and inu-
ential routes to lycopodine in 1982 (Scheme 13a).80–82 In
a remarkable sequence, intermediate 28 underwent depro-
tection, condensation and intramolecular Mannich reaction to
yield secondary amine 30, presumably via iminium ion 29. The
installation of the a-tertiary amine and the formation of two out
of four rings thus occurred in a single step, mimicking the
proposed biosynthesis of this natural product. Subsequent
optimization led to the shortest synthesis of lycopodine to date,Fig. 4 Representative Lycopodium alkaloids.
This journal is © The Royal Society of Chemistry 2016
Scheme 12 Representative lycopodine syntheses by Ayer (1968), Stork
(1968) and Wiesner (1967). Bn ¼ benzyl.
Scheme 14 Lycopodine syntheses by Kraus (1985) and Grieco (1998).
DBU ¼ 1,8-diazabicyclo[5.4.0]undec-7-ene.
























































































View Article Onlineconsisting of only eight steps.82 Using a similar sequence,
lycodine and lycodoline were prepared as well.82
Variations of Heathcock's strategy have been used in other
synthetic approaches toward Lycopodium alkaloids, e.g. in
syntheses of clavolonine by Evans (2005)84 and Fujioka (2011).83
One drawback of intramolecular Mannich reactions,
however, is the need to simultaneously form an iminium ion
and an enol. Thus, long reaction times of up to 18 days were
needed.82 Recently, this problemwas solved in an elegant way by
Carter (Scheme 13b).85,86 Using an aza-Wittig approach, Carter
was able to prepare and isolate the TBS–enol ether imine 31.
Treatment of 31 with zinc triate furnished the ATA and
concomitantly resulted in the rearrangement of the sulnyl
residue yielding lycopodine precursor 32.
In 1985, Kraus published a route towards lycopodine that
was based on the formation of a bridgehead olen (Scheme
14a).87 Tertiary alkyl bromide 33 was treated with DBU and 3-Scheme 13 Lycopodine syntheses by Heathcock (1982) and Carter
(2008). OTf ¼ trifluoromethanesulfonate, TBS ¼ tert-butyldimethylsilyl.
This journal is © The Royal Society of Chemistry 2016amino-1-propanol to install amino ketone 34, which could be
further transformed into the natural product in two additional
steps using Heathcock's protocol. An equally unusual approach
was reported by Grieco, who employed a Stieglitz rearrangement
(Scheme 14b).88 To effect the reaction, N-chloroamine 35 was
treated with silver tetrauoroborate followed by cyanoborohy-
dride. Many other syntheses of lycopodine have been accom-
plished utilizing different strategies, such as Michael additions,
for the assembly of the ATA.89–91
Members of the lycodine class of natural products feature an
ATA and a pyridine or pyridone moiety. The parent compound,
lycodine,92 was rst isolated from L. annotinum in 1958.93 ApartScheme 15 Synthesis of various Lycopodium alkaloids by Schumann
(1982) and Sarpong (2010). Ac ¼ acetyl.
Nat. Prod. Rep., 2016, 33, 491–522 | 497
Scheme 16 Syntheses of various Lycopodium alkaloids by Tsukano
(2010) and Takayama (2014). Cbz ¼ benzyloxycarbonyl, CSA ¼ cam-
phorsulfonic acid, Boc ¼ tert-butyloxycarbonyl, Bn ¼ benzyl, OTf ¼
trifluoromethanesulfonate.
Scheme 18 Huperzine A synthesis by Kozikowski (1989).
























































































View Article Onlinefrom the Heathcock synthesis mentioned above,82 several
additional syntheses of lycodine have been achieved to date.94–97
Schumann used a classical Mannich strategy to access
racemic lycodine, a-obscurine and N-acetylabellidine (Scheme
15).98–100
The mechanism of the key double Mannich reaction cascade
was further explored almost 30 years later by Sarpong.94 He used
the same cascade as an opening sequence in an asymmetric
synthesis of enantiomerically pure (+)-complanadine A, a lyco-
dine dimer, which was shown to enhance expression of nerve
growth factor in human cells.101 It was found that cyclic enam-
ide 36 opens to ketone 37 or enol 38 under acidic conditions,
which adds to the unsaturated bicyclic imine 39. Protonation of
the resulting enamine 40 triggers a second, intramolecular
Mannich reaction to afford tricycle 42 via the iminium ion 41.
Finally, an intramolecular enamide formation furnished tetra-
cyclic des-N-methyl-a-obscurine, containing the entire lycodine
framework.
In an unusual approach, Tsukano and Hirama applied an
intramolecular palladium-mediated Heck reaction betweenScheme 17 Lei's synthesis of ()-8-deoxyserratinine (2014). Boc ¼
tert-butyloxycarbonyl.
498 | Nat. Prod. Rep., 2016, 33, 491–522enecarbamate and pyridine triate 43 to form the ATA, which
yielded lycodine precursor 44 (Scheme 16a).95
Recently, another very short synthesis of ()-lycodine as well
as the closely related (+)-abellidine was accomplished by
Takayama (Scheme 16b).97 Starting from a linear precursor 45,
he was able to assemble the whole tetracyclic skeleton 48 of
both alkaloids in a cascade reaction involving a double
condensation (45 / 46), a conjugate addition (46 / 47) fol-
lowed by a Mannich reaction (47 / 48). In addition, Shair
published an approach towards several members of the 7-
membered-ring-containing Lycopodium alkaloids using a trans-
annular Mannich reaction (not shown).102,103
One of the rare cases of a SN2 reaction in ATA formation can
be found in Lei's recent synthesis of ()-8-deoxyserratinine
(Scheme 17).104 Tertiary alcohol 49 was converted into chloride
50, which was attacked intramolecularly by the free secondary
amine (50 / 51). In 2014, Lei extended his strategy to
a synthesis of the oxidised congener ()-serratinine.105 Other
approaches towards 8-deoxyserratinine and related alkaloids
include a Schmidt rearrangement and an intramolecular
epoxide opening.106–108
In contrast to the multiple strategies used for the installation
of ATAs in the Lycopodium alkaloids mentioned above, theScheme 19 Huperzine A syntheses by Sun/Lin (2012) and White
(2013). Boc ¼ tert-butyloxycarbonyl, p-TsCl ¼ para-toluenesulfonic
acid.
This journal is © The Royal Society of Chemistry 2016
Scheme 20 Overman's syntheses of misassigned nankakurine A
(2008) and revised nankakurines A and B (2010). Bn ¼ benzyl, Bz ¼
benzoyl, TFA ¼ trifluoroacetic acid, Ts ¼ para-toluenesulfonyl.
























































































View Article Onlinemethods used to access themedicinally important acetylcholine
esterase inhibitor huperzine A are less diverse. Since the ATA in
huperzine A is primary, it can be efficiently installed using
a Curtius rearrangement. Indeed, synthetic efforts towards
huperzine A were almost exclusively focused on carboxylic acid
precursors, such as 52.109–116
The rst synthesis of huperzine A was published by Kozi-
kowski in 1989 (Scheme 18).109 First, he completed the core 52
wherein the primary amine is replaced by a methyl ester. Aer
saponication, Curtius rearrangement (52 / 53) followed by
double deprotection provided racemic huperzine A. In the
following years, many huperzine A syntheses and several semi-
syntheses were published.117,118 All of them featured a racemic
or enantiomerically pure carboxylic acid derivative of precursor
53, keeping the Curtius rearrangement as the key step for the
formation of the ATA.109–116 These efforts culminated in the
recently published large-scale asymmetric synthesis of huper-
zine A.119Scheme 21 Porantherine synthesis by Corey (1974). p-TsOH ¼ para-
toluenesulfonic acid.
This journal is © The Royal Society of Chemistry 2016A few groups, however, have been able to avoid Curtius
rearrangements in the synthesis of huperzine A. Sun and Lin
accessed the alkaloid using an intramolecular Heck reaction
(54/ 55) (Scheme 19a),120 whereas the White group performed
an elegant tandem intramolecular aza-Prins cyclization/cyclo-
butane fragmentation (56 / 53) to set the ATA in 53 (Scheme
19b).121
Two Lycopodium alkaloids recently isolated from Lycopodium
hamiltonii, viz. the nankakurines A and B, have attracted broad
interest in the synthetic community (Fig. 4).122,123 So far, two
syntheses of these natural products have been reported. In
2008, Overman published an enantioselective synthesis of the
misassigned original structure of nankakurine A (61) (Scheme
20a) followed by the syntheses of the reassigned structures of
nankakurine A and B in 2010 (Scheme 20b).124,125
In the case of 5-epi-nankakurine (61), an aza-Prins reaction
(59 / 60) was used, which allowed for the direct formation of
both piperidine rings in 61 in one step starting from bicycle
59.124 This strategy, however could not be applied for the
formation of actual nankakurine A. Its synthesis was accom-
plished utilizing an intramolecular 1,3-dipolar cycloaddition of
an azomethine imine 63, formed in situ via condensation of 62
with formaldehyde. This reaction provided access to tetracyclic
pyrazolidine 64, which, aer SmI2 mediated N,N-bond cleavage,
gave rise to nankakurines A and B.125 Two years later, Waters
reported a racemic synthesis of nankakurines A and B using
a Grignard addition to an iminium species derived from luci-
duline, which is easily accessible by total synthesis (not
shown).126
Porantherine, the major alkaloid of the poisonous woody
shrub Poranthera corymbosa, is structurally similar to the Lyco-
podium alkaloids, although not a member of the family
(Fig. 4).127,128 Possessing two tertiary carbons attached to the
same amine (twofold ATA), porantherine is a considerable
synthetic challenge that has been met only twice thus far.129,130
Both syntheses are racemic and based on similar strategies for
the assembly of the ATAmotif, namely an addition to a ketimine
followed by Mannich reaction. Corey published his synthesis of
the natural product in 1974 (Scheme 21),129 only three years
aer its isolation. The rst ATA was installed through addition
of an organolithium compound to imine 65 to form 66, which
then cyclized to the corresponding enamine 67 upon treatment
with acid. The formation of the second ATA center through an
intramolecular Mannich addition (via iminium ion 68) fur-
nished ketone 69, which was eventually converted to the natural
product.
A second synthesis of porantherine, published by Stevens in
1987, involved the addition of two alkyllithium compounds to
an iminoether (not shown).130
6 Hasubanan alkaloids
The hasubanan alkaloids, isolated from various plant sources,
are structurally related to the better-known morphine alkaloids
but feature a pyrrolidine ring instead of a piperidine ring. They
are comprised of over 40 family members, all of which share the
same aza-propellane skeleton (Fig. 5).131Nat. Prod. Rep., 2016, 33, 491–522 | 499
Fig. 5 Representative hasubanan alkaloids.
Scheme 23 Syntheses of hasubanan alkaloids by Reisman (2011) and
Herzon (2011). t-Bu ¼ tert-butyl, TMS ¼ trimethylsilyl, OTf ¼
trifluoromethanesulfonate.
























































































View Article OnlineAlthough the physiological effects of the hasubanans are of
less signicance compared to the related morphine alkaloids,
their beautiful structures stimulated numerous synthetic
studies and several total syntheses have been reported to
date.132–146
The rst successful syntheses of ()-cepharamine,132,135
()-hasubanonine,134,137 ()-aknadilactam134 and ()-meta-
phanine136,138 were published by Inubushi in the 1970s (Scheme
22a). Starting from tricyclic b-tetralone 70, the ATA was set via
a cascade reaction involving an aza-Michael addition (71/ 74).
Almost 30 years later, Schultz prepared (+)-cepharamine using
a Hofmann-type rearrangement to introduce the ATA (not
shown).139
Recent years have seen revived interest in hasubanans. An
elegant method for the installation of the ATA was developed byScheme 22 Syntheses of hasubanan alkaloids by Inubushi (1969) and
Castle (2009). Bn ¼ benzyl, TBS ¼ tert-butyldimethylsilyl.
500 | Nat. Prod. Rep., 2016, 33, 491–522Castle, who closed the pyrrolidine ring of isohasubanonine
through a SN20-reaction.140,147 Subsequently, this strategy was
adapted to access ()-acutumine (Scheme 22b).142 To this end,
amine 75 was exposed to a Lewis acid to generate an allylic
cation that was intercepted by the appended secondary amine.
The resulting ATA-containing pyrrolidine 76 was then converted
into ()-acutumine.
In contrast to this approach, which sets the ATA at a rela-
tively late stage in the synthesis, Reisman installed it at the
beginning (Scheme 23a).144 Reaction of the chiral N-tert-buta-
nesulnimine 78 with phenethyl Grignard 77 provided sul-
namide 79 with a high degree of diastereoselectivity.
Subsequently, 79 was converted into a series of hasubanan
alkaloids such as ()-8-demethoxyrunanine.
The rst enantioselective synthesis of hasubanonine was
published by Herzon (Scheme 23b).143 Methylation of imino-
quinone Diels–Alder adduct 80 (80 / 81), followed by addition
of alkynyl lithium 82 gave amine 83, which was eventually
transformed into optically pure ()-hasubanonine. This
strategy proved to be versatile, as many more hasubanan alka-
loids, including ()-runanine, ()-delavayine, (+)-periglaucine B
and ()-acutumine, could be accessed by variation of the
alkynyl species.143,145,146
7 Stemona alkaloids
Plants belonging to the family Stemonaceae, which are mostly
found in Southeast Asia, have been used for centuries as
insecticides and for the treatment of respiratory diseases.148–150
Phytochemical investigations led to the isolation of a variety of
natural products known as Stemona alkaloids (Fig. 6).151,152
These polycyclic natural products possess highly complexThis journal is © The Royal Society of Chemistry 2016
Fig. 6 Representative Stemona alkaloids.
Scheme 25 Syntheses of Stemona alkaloids by Overman (2003) and
Huang (2015). ABCN ¼ 1,10-azobis(cyclohexanecarbonitrile), Bn ¼
benzyl, TBDPS ¼ tert-butyldiphenylsilyl, TIPS ¼ triisopropylsilyl.
























































































View Article Onlinestructures weaving together pyrrolidines and butenolides, oen
through spiro fusions that contain ATAs.
The structural beauty of these molecules generated consid-
erable interest in the synthetic community and stimulated the
development of new synthetic methods for the installation of
ATAs.151,152 The strategies employed range from classical addi-
tions to imines,153,154 to radical cyclization cascades,155,156 radical
allylations,157 semipinacol-Schmidt cascades,158,159 Schmidt
reactions,160 aza-Cope–Mannich reactions,161 cyclopropane-Cope
rearrangements162 and catalytic 1,3-dipolar cycloadditions.163
The rst synthesis of a Stemona alkaloid, viz. isostemofoline,
was published by Kende in 1999 and employed a highly unusual
and elegant approach.162 The ATA was formed via rhodium-
catalyzed reaction of pyrrole 84 with vinyl diazoester 85. TheScheme 24 Syntheses of Stemona alkaloids by Kende (1999), Ishibashi
(2008) and Zhang (2011). ABCN ¼ 1,10-azobis(cyclohexanecarboni-
trile), Boc ¼ tert-butyloxycarbonyl, MOM ¼ methoxymethyl, TBS ¼
tert-butyldimethylsilyl, TMS ¼ trimethylsilyl.
This journal is © The Royal Society of Chemistry 2016resultant divinyl cyclopropane 86 underwent Cope rearrange-
ment in situ to afford bicycle 87, which was then used as a key
intermediate in the further assembly of the natural product
(Scheme 24a).
More recently, two synthetic approaches aimed at members
of the stemonamine group were published. Ishibashi developed
an entry to racemic stemonamide and isostemonamide as well
as their reduced derivatives stemonamine and isostemon-
amine, based on a radical cascade as the key step for the
formation of the ATA (Scheme 24b).155,156 Treatment of the
achiral precursor 88 with tributyltin hydride and 1,10-azo-
bis(cyclohexanecarbonitrile) (ABCN) at elevated temperatures
effected a 7-endo-trig cyclization that likely yielded radical 89 as
the proposed intermediate, which in turn underwent an
unusual 5-endo-trig cyclization providing access to a separable
mixture of isomers 90 and 91. Further transformations of these
tricyclic compounds furnished stemonamide and some of its
congeners.
An alternative approach to stemonamide and related Ste-
mona alkaloids was published by Zhang (Scheme 24c).159 Based
on his systematic studies on the reactivity of a-hydroxy epoxides
such as 92,164 he developed a powerful cascade that combines
a semipinacol rearrangement with an Aubé–Schmidt reaction
(92/94). The resulting amide 94 was obtained as a 5 : 1
mixture of diastereomers, reecting the diastereomeric mixture
of propargylic azides employed as substrates. Using this strategy
and variations thereof, Zhang was able to synthesize stemona-
mide and three additional Stemona alkaloids, viz. maistemo-
nine, stemonamine, and isomaistemonine.158–160
The only synthesis of asparagamine A, an unsaturated
derivative of stemonamide, was achieved by Overman in 2003.161
He installed the ATA using his signature aza-Cope–Mannich
cascade (Scheme 25a). The synthesis of a precursor moleculeNat. Prod. Rep., 2016, 33, 491–522 | 501
Fig. 7 Indole alkaloids featuring ATAs.
























































































View Article Onlinesuitable for this transformation commenced with a Diels–Alder
reaction, forming an ATA that later took part in the rearrange-
ment. Treatment of 95 with excess paraformaldehyde at
elevated temperatures generated iminium ion 96, which
underwent the aza-Cope–Mannich sequence to afford the ATA
of asparagamine A (98, via intermediate 97). More recently,
a radical allylation (99 / 100) was utilized by Huang to set the
ATA in (+)-methoxystemofoline at an early stage of the synthesis
(Scheme 25b).157
8 Indole alkaloids
Indole alkaloids are a structurally and biosynthetically hetero-
geneous class of natural products characterized by an indole
nucleus or derivative thereof. Several of them, albeit not the best
known ones, contain ATAs (Fig. 7).
Kopsine, the rst member of the so-called Kopsia alkaloids,
was isolated as early as 1890,165 but it took several decades
before its complex structure, and those of its congeners, could
be elucidated.166–173 All members of this family possess an ATA
incorporated in a bicyclo[2.2.2]octane system. Thus, the kop-
sanes seem predestined for Diels–Alder reactions, and few
syntheses fail to employ a [4+2] cycloaddition strategy.174–176 The
routes used can be divided into two main categories: (a) inter-
molecular Diels–Alder reactions177–180 and (b) intramolecular
Diels–Alder reactions.181–185
The very rst synthesis of ()-aspidofractinine, completed in
1976, introduced an intermolecular Diels–Alder reaction to set
the ATA using nitroethylene as a dienophile (not shown).177 Over
time, phenyl vinyl sulfone emerged as a more practical dien-
ophile178,179 and in 2009 the rst enantioselective synthesis of
(+)-aspidofractinine was reported by Spino using this reagent
(Scheme 26a).180 In this case, imine 101 thermally isomerized to
diene 102, which then underwent cycloaddition from the
sterically more accessible convex side to afford sulfone 103.
The rst successful intramolecular Diels–Alder approach to
()-kopsanone and ()-10,22-dioxokopsane was reported in
1983 by Magnus (Scheme 26b).181,182 They synthesized sulde
104 as a suitable precursor, with the dienophile placed in the
concave position. The cycloaddition reaction proceeded at
100 C and provided intermediate 105, which was transformed
into ()-kopsanone in a few steps. Using a similar strategy,
other indole alkaloids, ()-kopsijasmine and ()-kopsine, were
prepared as racemates,184,185 as well as ()-kopsinilam and
()-kopsinine in enantiomerically pure form.183
In a recent example for an alternative approach by Boger,
a powerful radical transannular cyclization was applied to
install the ATA of kopsinine (Scheme 26c).176 Upon treatment of
xanthate 106 with SmI2, ATA 108 was formed as a single dia-
stereomer. Presumably, a primary radical intermediate 107 is
formed, which undergoes a radical cyclization followed by
reduction and diastereoselective protonation of the ester
enolate.
Lapidilectine B and lundurine A are two structurally related
Kopsia alkaloids that contain two ATAs. Although not origi-
nating from the same organism, they show a similar scaffold
with a bridged 8-membered ring fused to an indoline on one502 | Nat. Prod. Rep., 2016, 33, 491–522side and a 5-membered ring on the other. Lapidilectine A was
isolated by Awang from the leaves of the tree Kopsia lapidilecta
in 1992.186,187 Lundurines A–D were isolated from the Malaysian
tree Kopsia tenuis,188 and shown to be effective at bypassing
multidrug resistance in vincristine-resistant KB cells.189
Qin accomplished the rst enantioselective synthesis of
()-lundurine A in 2014 (Scheme 27a).190 The rst ATA was
established via the addition of allylmagnesium bromide to an
iminium ion generated by in situ alkylation of imine 109 to form
tetracycle 110. In order to establish the two fully substituted
stereocenters on the indoline of 112, Qin resorted to an unusual
intramolecular Simmons–Smith cyclopropanation of diiodideThis journal is © The Royal Society of Chemistry 2016
Scheme 26 Kopsia alkaloid syntheses by Spino (2009), Magnus (1983)
and Boger (2013). Bn ¼ benzyl, Ts ¼ p-toluenesulfonyl.
Scheme 27 Syntheses of Kopsia alkaloids by Qin (2014) and Pearson
(2001). Bn ¼ benzyl, TBDPS ¼ tert-butyldiphenylsilyl, TBS ¼ tert-
butyldimethylsilyl.
























































































View Article Online111. Two other racemic syntheses of lundurine A and B have
been reported by Nishida.191–193 He employed a Curtius rear-
rangement and a 1,2-addition to an iminium ion for lundurine
B193 and a Tsuji–Trost amination and an indoxyl bisalkylation
for the synthesis of lundurine A (not shown).191,192
In 2001, Pearson employed a Smalley cyclization of aryl
ketone azide 113 to furnish the spiroindoxyl 114 (Scheme
27b).194,195 In the nal steps of his lapidilectine B synthesis, he
then used his trademark azaallyl anion [3+2] cycloaddition to
establish the pyrrolidine ring (115 / 116) as an inconsequen-
tial mixture of regioisomers.
The cycloaddition approach has not been limited to the
kopsane alkaloids. Other indole alkaloids, such as stephacidin
A and the notoamides, which bear two ATAs, were prepared by
a presumably biomimetic [4+2] cycloaddition.
Williams synthesized stephacidin A and notoamide B start-
ing from imidate 117, which underwent base-mediated isom-
erization to 118 followed by intramolecular Diels–Alder reaction
to afford diazabicyclo[2.2.2]octane 119 (Scheme 28).196 This
remarkable reaction sets both ATAs in a single step. Later thatThis journal is © The Royal Society of Chemistry 2016year, stephacidin B was accessed via avrainvillamide using the
same strategy.197
In 2005, Baran used the a-alkylation of proline derivative 120
with complete chirality transfer, a method developed by See-
bach,198 to set the rst ATA of stephacidin A in 121 (Scheme
29).199 The second ATA present in 123 was installed by an
intramolecular, stereocontrolled oxidative enolate coupling
starting from diketopiperazine 122. Baran was then able to
convert stephacidin A into avrainvillamide and stephacidin B
following a biosynthetic proposal.200
A second synthesis of avrainvillamide and stephacidin B was
accomplished concurrently by Myers (Scheme 30).201 In this
case, the rst ATA was installed by a Strecker-type addition of
TMS cyanide to enamine 124 to form the N-Boc amino nitrile
125. The second ATA was then set by a very unusual radical
transfer cyclization. Abstraction of a hydrogen atom in 126,
followed by loss of toluene, generates an aminoacyl radical
which attacks the enamide double bond and ejects a phenylthiyl
radical to form the diketopiperazine 127.
Several members of a related family of prenylated spiroox-
indole alkaloids, namely cyclopiamine, citrinadin A and cit-
rinadin B, also feature an asymmetric ATA.202–204 In 2013, Martin
andWood reported the rst syntheses of citrinadin A and B.205,206Nat. Prod. Rep., 2016, 33, 491–522 | 503
Scheme 28 Synthesis of prenylated indole alkaloids by Williams
(2007).
Scheme 30 Synthesis of prenylated indole alkaloids by Myers (2005).
t-amyl ¼ tert-amyl (2-methylbutyl), Boc ¼ tert-butyloxycarbonyl,
HFIPA ¼ 1,1,1,3,3,3-hexafluoroisopropyl alcohol, TBDPS ¼ tert-butyl-
diphenylsilyl, TMSCN ¼ trimethylsilyl cyanide.
























































































View Article OnlineIn the case of citrinadin A, epoxide 128 was heated in the pres-
ence of methylamine to provide 1,2-amino alcohol 129 (Scheme
31a).205 Wood's approach employed an azide-mediated opening
of epoxide 130 to establish the ATA in 131 (Scheme 31b).206 Both
reactions are rare examples where an ATA has been set through
a SN2 reaction.
More recently, Sarpong published his entry to the prenylated
indole alkaloids cyclopiamine B and ent-citrinalin B (Scheme
32). The rst ATA was set via a Hofmann rearrangement (132/
133).207 The second, not asymmetric, ATA center was established
by treating ent-citrinalin B with sodium hydride to effect the
rearrangement of the chromanone to the tetrahydroquinoloneScheme 29 Synthesis of prenylated indole alkaloids by Baran (2005).
acac ¼ acetylacetonate, Boc ¼ tert-butyloxycarbonyl, t-Bu ¼ tert-
butyl, LDA ¼ lithiumdiisopropylamide.
504 | Nat. Prod. Rep., 2016, 33, 491–522moiety present in cyclopiamine via retro-Michael/Michael
addition. Using a similar approach, he was then able to
synthesize the structurally related alkaloids stephacidin A and
notoamide B.208
Two alkaloids closely related to notoamide B, marcfortine B
and C, were synthesized by Trost using a Michael addition and
a radical cyclization to set the two ATAs (not shown).209,210
Gelsemoxonine is an indole alkaloid with an ATA that is part
of a azetidine, a rare structural motif. It is also a member of theScheme 31 Syntheses of prenylated indole alkaloids by Martin (2013)
and Wood (2013).
This journal is © The Royal Society of Chemistry 2016
Scheme 32 Synthesis of ent-citrinalin B and ()-cyclopiamine B by
Sarpong (2015). PIFA ¼ (Bis(trifluoroacetoxy)iodo)benzene.
Scheme 34 Syntheses of welwitindolinones by Rawal (2011) and Garg
(2011). BAIB ¼ (diacetoxyiodo)benzene, NCS ¼ N-chlorosuccinimide,
OTf ¼ trifluoromethanesulfonate, Ph ¼ phenyl.
























































































View Article OnlineGelsemium spirooxindole family, a large alkaloid family with
highly compact, strained and complex structures, which have
attracted considerable synthetic activity.211–213 In 2011,
Fukuyama accomplished a total synthesis of gelsemoxonine
that employed an intramolecular epoxide opening of 134 to
install the ATA (Scheme 33a).214 Recently, Carreira published an
elegant entry to gelsemoxonine, setting the ATA 136 via a dia-
stereoselective propynyllithium addition to isoxazoline 135
(Scheme 33b).215
The welwitindolinones are another class of indole alkaloids
with an ATA that is not part of the indole-derived moiety itself.
The rst welwitindolinone natural products (Fig. 7) were iso-
lated by Moore in 1994 from the cyanobacteria Hapalosiphom
welwitschii and Westiella intracta.216 All welwitindolinones
known so far feature a [4.3.1] bicyclic framework, which, in
some cases, contains a modied ATA that bears an iso-
thiocyanate or isonitrile functional group.217,218
Being a considerable challenge for total synthesis, the wel-
witindolinones have become popular targets.219 The rst total
synthesis of N-methylwelwitindolinone D isonitrile was
accomplished by Rawal in 2011220–222 using Kim's oxime rear-
rangement to install the isothiocyanide (137 / 138, Scheme
34a).223,224 Desulfuration of 138 then gave the naturally occuringScheme 33 Syntheses of gelsemoxonine by Fukuyama (2011) and
Carreira (2013). Boc ¼ tert-butyloxycarbonyl.
This journal is © The Royal Society of Chemistry 2016isonitrile. Martin completed a synthesis that intercepts Rawal's
synthesis in 2012.225
Garg's total synthesis of N-methylwelwitindolinone C iso-
thiocyanate used an intramolecular Ag-mediated nitrene C,H-
insertion of amide 139 as the critical step, which furnished
carbamate 140 (Scheme 34b).226,227 To improve the regiose-
lectivity and yield of this late stage transformation, the authors
beautifully exploited the deuterium kinetic isotope effect.228
Both Rawal and Garg were able to subsequently synthesize
several members of the welwitindolinone family by varying their
initial strategies.222,228–230 In addition, Hatakeyama recently
accomplished another synthesis of ()-N-methylwelwitindolinone
C isothiocyanate using an endgame similar to Rawal's.231
Two examples of reactions which have been specically
developed to set an ATA, both explored by the Baran laboratory,
are shown in Scheme 35.
In the synthesis of chartelline C, the ATA was set via
a cascade reaction initiated by the bromination of indole 141 at
185 C resulting in 142 (Scheme 35a). Amide attack furnished
intermediate 143, which then rearranged in a 1,5-shi to give
the ring contracted spiro-b-lactam 144.232,233 For the synthesis of
psychotrimine, a coupling of indole 147with 2-iodoaniline (146)
was developed to yield 148, which then underwent further
cyclization to give 149 (Scheme 35b).234 This method was also
used for the syntheses of psychotetramine,235 kapakahine B and
kapakahine F.236,237
Another interesting way to install an ATA in a structurally
complex indole alkaloid was published by Danishefsky (Scheme
36).238 In his synthesis of the furanobisindole alkaloid phalar-
ine, amino acid derivative 150 was treated with formaldehyde
and acid to set the ATA in a diastereoselective fashion (150 /
152). It is not clear, however, whether this reaction proceeds via
a 1,2-Wagner–Meerwein shi (possible intermediate 153) orNat. Prod. Rep., 2016, 33, 491–522 | 505
Scheme 35 Baran's syntheses of chartelline C (2006) and psycho-
trimine (2008). Bn ¼ benzyl, Boc ¼ tert-butyloxycarbonyl, NBS ¼ N-
bromosuccinimide, NIS ¼ N-iodosuccinimide, TMSE ¼ 2-(trime-
thylsilyl)ethyl.
Scheme 36 Danishefsky's synthesis of phalarine (2010). Bn ¼ benzyl,
CSA ¼ camphorsulfonic acid.
506 | Nat. Prod. Rep., 2016, 33, 491–522
























































































View Article Onlinea Pictet–Spengler reaction (possible intermediate 154) starting
from iminium intermediate 151.
9 Cephalotaxines
Due to their interesting chemical structure and antileukemic
activities, the cephalotaxines, isolated from the Japanese plum
yew (Cephalotaxus harringtonii), have emerged as popular
targets for natural product synthesis (Fig. 8).239
The rst synthesis of cephalotaxine itself was reported by
Weinreb in 1972 (Scheme 37a).240 Conversion of enamine 155
into diketone 156 set the stage for a Lewis-acid catalyzed cycli-
zation to yield tertiary amine 158 (via intermediate 157).
Weinreb was able to synthesize cephalotaxine in six additional
steps with an overall yield of 20%, setting a high bar for the
following syntheses.
In 1988, Fuchs utilized an intramolecular [4+2] nitroso-
Diels–Alder cycloaddition to assemble the benzazepine 161
from hydroxamic acid 159 (via intermediate 160, Scheme
37b).241
Tietze published a formal asymmetric synthesis of
()-cephalotaxine in 1999 that is based on palladium catalysisFig. 8 Representative cephalotaxines.
Scheme 37 Syntheses of Cephalotaxine by Weinreb (1972) and Fuchs
(1988).
This journal is © The Royal Society of Chemistry 2016
Scheme 38 Syntheses of cephalotaxine by Tietze (1999) and Li (2003).
Ac ¼ acetyl, TMG ¼ 1,1,3,3-tetramethylguanidine.
Scheme 40 Syntheses of cephalotaxine by Mariano (2006), Hayes
(2008) and Ishibashi (2008). ABCN ¼ 1,10-azobis(cyclohex-
anecarbonitrile), Boc ¼ tert-butyloxycarbonyl, TBS ¼ tert-butyldime-
thylsilyl, TBDPS ¼ tert-butyldiphenylsilyl, TMS ¼ trimethylsilyl.
























































































View Article Online(Scheme 38a).242 A Tsuji–Trost allylation on secondary amine
162 established the ATA and afforded 163 which was converted
into cephalotaxine via a subsequent Heck reaction. A similar
Tsuji–Trost allylation was used by Stoltz in 2007 in his synthesis
of drupacine and cephalotaxine.243
A [2,3] sigmatropic rearrangement was utilized by Li to
convert quaternary ammonium ion 165 to the a-tertiary amino
ester 166 (164 / 166, Scheme 38b).244
A rather unusual approach for the asymmetric synthesis of
()-cephalotaxine was pursued by Royer, who introduced theScheme 39 Syntheses of cephalotaxines by Royer (2004) and Gin
(2006). Ar ¼ aryl, OTf ¼ trifluoromethanesulfonate, Piv ¼ pivaloyl,
TBAT ¼ tetrabutylammonium difluorotriphenylsilicate.
This journal is © The Royal Society of Chemistry 2016ATA on key intermediate 169 via semipinacol rearrangement of
chiral a-hydroxyiminium 168. The latter was generated by acid-
catalyzed isomerization and protonation of pyrrolinone 167
(Scheme 39a).245
Another synthesis was developed by Gin, who transformed
vinylogous amide 170 into azomethine ylide 171 which then
underwent 1,3-dipolar cycloaddition with phenyl vinyl sulfone
to yield 172 (Scheme 39b).246,247 The unexpected yet advanta-
geous stereochemical outcome of this cycloaddition was
conrmed by X-ray analysis.
In 2006, Mariano used a photochemical cyclization of
a bicyclic pyridinium ion 173 to afford aziridine 174, which was
then transformed into the natural product (Scheme 40a).248
Hayes' synthetic route towards ()-cephalotaxine made use of
an alkylidene carbene 1,5-C,H-insertion starting from ketone
175 to furnish spiro[4.4]azanonane 177, which corresponds to
the skeleton of cephalotaxine (175 / 177, Scheme 40b).249
Ishibashi chose a radical cyclization approach to synthesize
cephalotaxine (Scheme 40c).250 Treatment of aryl iodide 178
with tributyltin hydride and a radical initiator resulted in a 7-
endo cyclization followed by a 5-endo cyclization that, aer
hydrogen transfer, yielded 179. Additional functional group
manipulations allowed them to intercept an intermediate that
had previously been used to synthesize ()-cephalotaxine.251
A host of other methods have been used for the installation
of the ATA in cephalotaxines.239 These include alkylation,252,253
Claisen rearrangement,254 Michael addition,255,256 SchmidtNat. Prod. Rep., 2016, 33, 491–522 | 507
























































































View Article Onlinereaction,257 addition to an imine,258 transannular cyclization259
and oxidative rearrangement.251Scheme 41 Syntheses of Erythrina alkaloids by Ishibashi (1990 and
2003) and Tsuda (1992). Ac¼ acetyl, OTf¼ trifluoromethanesulfonate,
TMS ¼ trimethylsilyl, p-TsOH ¼ para-toluenesulfonic acid.10 Erythrina alkaloids
Erythrina alkaloids were discovered at the end of the 19th
century, when extracts of Erythrina trees were found to possess
curare-like neuromuscular activities.260 Due to their biological
activities and interesting structures (Fig. 9), several total
syntheses of these natural products have been carried out and
many creative ways to install ATAs have been developed in this
context.261
In 1990, the group of Ishibashi published the synthesis of
()-3-demethoxyerythratidinone using an intramolecular Pum-
merer-like rearrangement of the enamine 180, setting the stage
for a Pictet–Spengler-type reaction (181 / 182) to furnish the
ATA (Scheme 41a).262 Thirteen years later, the same group
published an oxidative radical cyclization starting from
enamine 183 to obtain the skeleton of 3-demethoxyery-
thratidinone 182 (Scheme 41b).263
Tsuda's approach featured an intermolecular photochemical
[2+2] cyclization to install the ATA, starting from bicycle 184 and
diene 185 (Scheme 41c). In the following steps, a ring expansion
of the four-membered ring in 186 furnished the six-membered
ring by a formal 1,3-migration of a vinylcyclobutane, affording
the scaffold of erysotrine.264
Funk accomplished the synthesis of isophellibiline via an
approach that relies on pericyclic reactions (Scheme 42a).265
Heating of dioxine 187 resulted in retro-Diels–Alder reaction to
afford dehydroalanine derivative 188, which then underwent
intramolecular [4+2] cycloaddition to yield lactam 189. The
latter was converted into isophellibinine in a few steps.
Recently, Sarpong developed a new methodology to furnish
ATAs and applied it to the synthesis of cocculolidine (Scheme
42b).266 Propargylic alcohol 190 underwent cycloisomerization
upon heating to form benz[g]indolizinone 191 which was then
transformed to cocculidine in two additional steps.
A short and elegant synthesis of 3-demethoxyerythratidinone
was accomplished by Streuff in 2015 (Scheme 43a). He used
a titanium(III)-catalyzed reductive Umpolung (192 / 194) to
assemble the 1,1-disubstituted tetrahydroisoquinoline core of
the Erythrina alkaloids.267 In the same year, Ciufolini set the
same ATA via an oxidative dearomatizative cyclization of an
oxazoline 195, yielding spiropiperidine 197 presumably via
intermediate 196 (Scheme 43b).268,269Fig. 9 Representative Erythrina alkaloids.
Scheme 42 Syntheses of Erythrina alkaloids by Funk (2012) and Sar-
pong (2013).
508 | Nat. Prod. Rep., 2016, 33, 491–522 This journal is © The Royal Society of Chemistry 2016
Scheme 43 Syntheses of Erythrina alkaloids by Streuff (2015) and
Ciufolini (2015). HFIP ¼ 1,1,1,3,3,3-hexafluoroisopropyl alcohol, PIFA ¼
(bis(trifluoroacetoxy)iodo)benzene, TMS ¼ trimethylsilyl.
Fig. 10 Selection of quinolizidine alkaloids, including halichlorine and
the closely related alkaloids tauropinnaic acid and pinnaic acid.
























































































View Article OnlineOther methods used to install the ATA in Erythrina alkaloids
include 1,2-addition of organometallic reagents to sulnimines
or iminium ions,270–272 Schmidt reaction,273 Diels–Alder reac-
tions,274 Michael addition,275 N-acyliminium Pictet–Spengler
reaction276–278 and Heck reaction.27911 Indolizidine and quinolizidine
alkaloids
A range of alkaloids that belong to the indolizidine and qui-
nolizidine structural class feature an ATA in their carbon skel-
eton.280 They include natural products as diverse as the
cylindricines,280,281 FR901483,282 himandrines, lep-
adiformines283 and halichlorine284 (Fig. 10).
The rst synthesis of cylindricine alkaloids (viz. cylindricine
A, D and E) was accomplished by Snider utilizing a double
Michael addition of ammonia to divinylketone 198 which gave
the ATA 199, a direct precursor of cylindricine A (Scheme 44a).285
Variations of this approach have been used several times in the
synthesis of cylindricines.286
In 2003, Padwa published a synthesis featuring a Michael
addition/dipolar cycloaddition cascade between butadiene 201
and oxime 200 to form 203 via intermediate 202 (Scheme 44b).287
The Hsung synthesis of enantiomerically pure cylindricine C
relies on a nucleophilic attack of a diene on N-acyliminium ion
205 starting from ketone 204 (Scheme 45).288,289 This vinylogousThis journal is © The Royal Society of Chemistry 2016aza-Prins approach was based on a synthesis published by
Kibayashi in 2005.290
Additional strategies to synthesize the ATA in cylindricine
alkaloids involve mainly Michael additions,286,291,292 Grignard
additions to an imine,293 a cycloaddition of an alkyne to
a pyrrole derivative,294 and carboazidation.295
FR901483, an alkaloid isolated from the fermentation broth
of a Cladobotryum species with an intricate tricyclic structure,282
proved to be an equally popular synthetic target. A biomimetic
approach was employed by Sorensen in his enantioselective
synthesis (Scheme 46a).296
The oxidative azaspiroannulation of amine 207 promoted by
(diacetoxyiodo)benzene resulted in the formation of spiroamine
208, an intermediate on the way to the natural product. The
same year, Ciufolini set the ATA via a closely related oxidative
spiroannulation (not shown, for an example of the methodology
see Scheme 43b).297
An alternative to this strategy was found by Wang.298 In this
case, an Aubé–Schmidt reaction of azide 209 provided access to
lactam 212, featuring the ATA of FR901483 (209/ 212, Scheme
46b). Additional synthetic strategies to set the ATA in FR901483
include a triple Michael addition,299 a one-pot bisalkyla-
tion,300,301 an aza-Cope rearrangement/Mannich cyclization302,303
and an oxidative dearomatization.297
The members of the galbulimima alkaloid family, such as
himgaline and himandrine, also possess an ATA-containing
quinolizidine core (Fig. 10). Exploring a biosynthetic hypoth-
esis, Chackalamannil used an intramolecular Michael addition
to convert GB 13 to himgaline via ketone 213 (Scheme 47a).304,305
In an interesting variation of this apporach, Movassaghi con-
verted enone 214 via its a-chloroester 215 to hexacyclic amine
216, which could then be transformed into himandrine.
(Scheme 47b).304
In 1996, Uemura disclosed a small series of unusual marine
alkaloids featuring ATAs. One of these compounds,Nat. Prod. Rep., 2016, 33, 491–522 | 509
Scheme 44 Synthesis of cylindricines by Snider (1997) and Padwa
(2003). Boc ¼ tert-butyloxycarbonyl, TBDPS ¼ tert-butyldiphenylsilyl.
Scheme 46 Syntheses of FR901483 by Sorensen (2000) and Wang
(2012). Ar ¼ aryl, BAIB ¼ (diacetoxyiodo)benzene, Bn ¼ benzyl, TBDPS
¼ tert-butyldiphenylsilyl.
























































































View Article Onlinehalichlorine, was isolated from the marine sponge Halichondria
okadai and was found to selectively inhibit the induction of
vascular cell adhesion molecule-1 (VCAM-1).306 Pinnaic acid and
tauropinnaic acid were recovered from bivalve Pinna mur-
icata.307,308 All three molecules present a challenging 6-aza-spiro
[4.5]decane core containing the ATA. The latter two lack a qui-
nolizidine moiety, but are included in this chapter due to their
close structural relationship.
Danishefsky and Trauner were the rst to report the
synthesis of (+)-halichlorine in 1999309 followed by a synthesis of
pinnaic acid in 2001 (Scheme 48).310,311 They used Meyers' lac-
tam 217 as a chiral precursor, which was combined with allyl-
trimethylsilane in a Sakurai reaction to install the ATA in 218.
Intermediate 219 could be diversied to reach both halichlorine
and pinnaic acid. These syntheses established the absolute
conguration of halichlorine and conrmed the stereochem-
istry at C-14 and C-17 of pinnaic acid.
A related apporach employing a different type of N-acyl
iminium ion was used by Heathcock in 2004 for the synthesis of
halichlorine, pinnaic acid and tauropinnaic acid (Scheme
49a).312 Treatment of carbamate acetal 220 with allyl trime-
thylsilane and titanium tetrachloride furnished ATA-bearingScheme 45 Synthesis of cylindricine C by Hsung (2004). Boc ¼ tert-
butyloxycarbonyl, TBDPS ¼ tert-butyldiphenyl-silyl.
510 | Nat. Prod. Rep., 2016, 33, 491–522carbamate 221 with a high degree of stereoselectivity. This key
intermediate could be transformed into all three natural
products.
In 2007, Arimoto reported his version of an asymmetric
synthesis of pinnaic acid using a Beckmann rearrangement to
install the ATA (Scheme 49b).313 The enantiomerically pure
bicyclic ketone 222 was treated with a bulky hydroxylamineScheme 47 Synthesis of galbulimima alkaloids by Chackalamannil
(2009) and Movassaghi (2009). Ac ¼ acetyl, Bz ¼ benzoyl, NCS ¼ N-
chlorosuccinimide, OTf ¼ trifluoromethanesulfonate.
This journal is © The Royal Society of Chemistry 2016
Scheme 48 Synthesis of halichlorine and pinnaic acid by Danishefsky
and Trauner (1999). TBDPS ¼ tert-butyldiphenylsilyl, TMS ¼
trimethylsilyl.
Scheme 49 Syntheses of halichlorine, pinnaic acid and tauropinnaic
acid by Heathcock (2004) and Arimoto (2007). Cbz ¼ benzyloxy-
carbonyl, PMP ¼ p-methoxyphenyl, TMS ¼ trimethylsilyl.
Fig. 11 Lactacystin and salinosporamide A.
























































































View Article Onlinereagent to afford the desired lactam 223, which was then con-
verted into the natural product.Scheme 50 Syntheses of lactacystin by Corey (1992), Shibasaki (2006)
and Hayes (2008). Ac ¼ acetyl, DBU ¼ 1,8-diazabicycloundec-7-ene,
HMDS ¼ bis(trimethylsilyl)amine, PMB ¼ paramethoxybenzyl, TMS ¼
trimethylsilyl.12 Lactacystine and salinosporamide
In 1991, Omura isolated the unusual natural product lactacystin
from Streptomyces sp. OM-6519 and identied it as a proteasome
inhibitor (Fig. 11).314,315 A structurally related b-lactone, salino-
sporamide A, which shows similar biological activity, was subse-
quently isolated from a marine bacterium, Salinispora tropica.316
Both compounds possess a densely functionalized g-lactam
core with three contiguous stereocenters, one of which is of theThis journal is © The Royal Society of Chemistry 2016ATA type. Their signicant biological activity has stimulated
a large number of total syntheses,317 and a variety of methods
for the installation of the ATA motif have been applied.318–345
In pioneering work, Corey reported ve total syntheses of
lactacystin between 1992 and 1998.318–320,326,327 The Corey group
showed that the ATA can be installed using an aldol addition of
a-amino acid derivative 224 (via intermediate 225, Scheme 50a).
Other groups also contributed to this eld in the 1990s.321–325,328
In most cases, the strategy applied for the installation of the
ATAmotif involved an alkylation or aldol reaction of an a-amino
acid derivative.318–322,324,326–328 By contrast, Shibasaki introduced
the ATA with a catalytic enantioselective Strecker reaction
(Scheme 50b).317,334 In this work, phosphinoylimine 226 was
converted to aminonitrile 227 using a gadolinium catalyst and
the chiral ligand A.
Another unusual approach was taken by Wardrop346 in his
formal synthesis and Hayes338 in his total synthesis of lacta-
cystin (Scheme 50c). Both groups explored an intramolecular
carbene insertion into a C,H-bond to form the ve-membered
heterocyclic core. Hayes converted the enantiomerically pureNat. Prod. Rep., 2016, 33, 491–522 | 511
Scheme 51 Syntheses of salinosporamide A by Corey (2004) and Sato
(2011). Bn ¼ benzyl, LDA ¼ lithium diisopropylamide, TMS ¼
trimethylsilyl.
Fig. 12 Manzacidin A and C.
























































































View Article Onlinevinyl bromide 229 to the corresponding vinylidene carbene,
which underwent cyclization to afford 230 in high yield.
The rst synthesis of salinosporamide was reported by Corey
in 2004.330,331 In this case, the ATA was installed by alkylation of
threonine-derived oxazoline 231 with chloromethyl benzyl ether
(via intermediate 232, Scheme 51a).
A more recent synthesis of salinosporamide A published by
Sato and Chid uses a stereoselective Overman rearrangement to
install the ATA (Scheme 51b).343 Heating of the highly func-
tionalized trichloroacetimidate 233 provided tri-
chloroacetamide 234 as a key intermediate.
Other syntheses of salinosporamide and lactacystine used
different strategies for the formation of the ATA, such as
intramolecular aldol reactions,336,337 intramolecular acyla-
tions,332 acid catalyzed cyclizations of malonates,335,339 indium-
catalyzed Conia-ene reactions,341 C,H-alkynylation347 and enzy-
matic desymmetrizations of prochiral ATAs.340Scheme 52 Syntheses of manzacidins by DuBois (2002) and Leighton
(2008). Ac ¼ acetyl, BAIB ¼ (diacetoxyiodo)benzene, OTf ¼ tri-
fluoromethanesulfonate, i-Pr ¼ iso-propyl, TBDPS ¼ tert-
butyldiphenylsilyl.13 Manzacidins
The manzacidins, a small family of bromopyrrole alkaloids,
have attracted considerable attention from the synthetic
community despite, or maybe because of their relatively simple
structures. Manzacidins A–C (Fig. 12) were rst isolated form
the Okinawan spongeHymeniacidon sp. by Kobayashi in 1991,348
followed by the isolation of manzacidin D from the ‘living fossil’
sponge Astrosclera willeyana349 and N-methylmanzacidin C from
Axinella brevistyla.350
In 2000, Ohfune reported the synthesis of manzacidins A and
C via a Strecker reaction and assigned the absolute congura-
tion of these natural products (not shown).351 In 2002, DuBois
synthesized manzazidin C using an elegant oxidative C,H-
insertion that involved sulfamate 235 (via intermediate 236,
Scheme 52a).352 One year later, he used a similar strategy to set
the ATA in tetrodotoxin (see chapter 14, Scheme 54c).353
Leighton accomplished the synthesis of manzacidin C
employing their asymmetric silane-promoted [3+2]512 | Nat. Prod. Rep., 2016, 33, 491–522cycloaddition methodology (Scheme 52b).354 Exposure of alkene
237 and hydrazone 238 to chiral silane R,R-B gave pyrazolidine
239, thus setting both stereocenters of the target molecule,
including the ATA, in a single step. Intermediate 239 was
subsequently converted to manzacidin C via reductive N,N-
bond cleavage.
A more recent formal synthesis of manzacidins A and C,
published by Ichikawa, features a rare allyl cyanate/isocyanate
rearrangement as the key step (Scheme 53).355 To this end, he
synthesized carbamate 240, which was converted to allyl cyanate
241 by in situ dehydration. The subsequent rearrangement with
chirality transfer gave isocyanate 242, which was then trans-
formed into manzacidin A. The synthesis of manzacidin C was
accomplished analogously from a diastereoisomer of carbamate
240.355
Several other synthetic approaches toward these molecules
have been reported. These strategies for the installation of the
ATA moiety involve diastereoselective nitrene insertion,352 1,3-
dipolar cycloaddition,356,357 Hofmann rearrangement,358 dia-
stereoselective iodocyclization,359,360 Grignard addition to an
imine361 and a variety of other methods.362–366 Indeed, man-
zacidines remain targets of great interest for synthetic chemists.
In 2015, Inoue published a synthesis of manzacidin A using
a radical-based decarbonylative coupling (not shown).367
Recently the relative stereochemistry of manzacidin B, which
possesses an additional stereocenter, was revised using total
synthesis.362,363,365This journal is © The Royal Society of Chemistry 2016
Scheme 53 Synthesis of manzacidin A by Ichikawa (2012). Boc ¼ tert-
butyloxycarbonyl, Cbz ¼ benzyloxycarbonyl.
























































































View Article Online14 Tetrodotoxin
Tetrodotoxin (TTX) was rst isolated from the Fugu puffer sh
in 1909.368,369 Its structure was independently reported by Hir-
ata–Goto,370 Tsuda371 and Woodward372 in the 1960s. Their
assignment was conrmed by X-ray crystallography, which also
established the absolute conguration of the molecule.373,374
TTX features a highly functionalized heteroadamantane
framework that contains an ortho-acid and is fused to a cyclic
guanidinium moiety via an ATA motif. The molecule is an
extremely powerful and selective blocker of voltage-gated
sodium channels and is widely used as a research tool in
neuroscience.375–379 Due to its intriguing structure and bioac-
tivity, attempts to synthesize TTX have been made from an early
stage and activity in this eld has recently increased
signicantly.380Scheme 54 Syntheses of tetrodotoxin (TTX) by Kishi (1972), Isobe
(2003) and DuBois (2003). Ac ¼ acetyl, BAIB ¼ (diacetoxyiodo)
benzene, Ms ¼ methanesulfonyl, Ph ¼ phenyl,.
This journal is © The Royal Society of Chemistry 2016The rst total synthesis of TTX was accomplished by Kishi in
1972 (Scheme 54a).381–384 In his approach, the ATA was formed
using a Beckmann rearrangement of oxime 243, which was
synthesized using a regioselective Diels–Alder reaction. The
resulting key intermediate 244 was converted into TTX using
a series of stereoselective redox transformations, ring cleavage
and the installation of the cyclic guanidine with newly devel-
oped methodology. Although the Kishi synthesis was not
enantioselective, it still stands as one of the strategically most
elegant approaches to a natural product featuring an ATAmotif.
Aer a 30 year lull, Isobe published the rst enantioselective
synthesis of TTX wherein the ATA motif was installed with
a stereoselective Overman rearrangement (Scheme 54b).385–387
To this end, an allylic alcohol was converted to tri-
chloroacetimidate 245, which underwent rearrangement to
yield trichloroacetamide 246. Compound 246 bears all the
carbon atoms of TTX and could be converted into the natural
product in a series of steps.
Shortly thereaer, DuBois developed an enantioselective
approach to TTX that involved his signature nitrene insertion
chemistry (Scheme 54c).353 Exposure of the key intermediate,
carbamate 247, to a hypervalent iodine reagent and magnesium
oxide in the presence of a rhodium catalyst led to the formation
of oxazolidinone 248, which bears the ATA motif. Insertion into
other possible C,H-bonds was largely avoided through careful
engineering of the substrate.
15 Miscellaneous alkaloids
ATA's occur in many other alkaloids that cannot easily be
categorized along the biosynthetic and structural lines shown
above. An example is gracilamine, which was isolated in 2005 by
Ünver and Kaya from the Amaryllidacae species Galanthus gra-
cilis.388 In 2012, the rst synthesis of gracilamine was disclosed
by Ma (Scheme 55a).389 It relies on a potentially biomimetic,
stereoselective and intramolecular [3+2] cycloaddition, trans-
forming 249 into the highly functionalized pyrrolidine 250.
In a recent synthesis, Gao set the ATA via an intramolecular
Mannich annulation (Scheme 55b).390 First, a-ketoester 252 was
condensed with amine 251. The resulting iminium ion 253 then
underwent a diastereoselective Mannich reaction to furnish the
hexacyclic scaffold 254 of gracilamine.
The amathaspiramides A–F are a family of marine alkaloids
isolated from the bryozoan Amathia wilsoni in 1999 (Fig. 13).391
They feature an unusual spirocyclic core consisting of a pyrro-
lidine fused to a pyrrolidinone moiety.391
The rst total synthesis of a member of this family, viz.
amathaspiramide F, was disclosed by Trauner in 2002 (Scheme
56a).392 In this work, the proline-derived N,N-acetal 255 was
converted to the corresponding silyl ketene acetal, which
underwent a diastereoselective Michael addition to the nitro
olen 256, establishing the ATA of 257. Subsequently, Ohfune
published his approach to amathaspiramide F which utilizes an
enolate Claisen rearrangement for the same purpose (not
shown).393
In 2012, Fukuyama reported the asymmetric synthesis of the
entire amathaspiramide family (Scheme 56b).394 In their work,Nat. Prod. Rep., 2016, 33, 491–522 | 513
Scheme 55 Syntheses of gracilamine by Ma (2012) and Gao (2014).
TBDPS ¼ tert-butyldiphenylsilyl, Troc ¼ 2,2,2-trichlorethoxycarbonyl,
TFA ¼ trifluoroacetic acid.
Scheme 56 Syntheses of amathaspiramides by Trauner (2002) and
Fukuyama (2012). Bn ¼ benzyl, t-Bu ¼ tert-butyl, TBS ¼ tert-
butyldimethylsilyl.
























































































View Article Onlinethe benzyl ester 258 bearing a quaternary stereocenter was rst
deprotected and the resulting acid converted to the corre-
sponding amine via Curtius rearrangement. Aer hydrolysis of
the resulting isocyanate, the intermediate amino ester under-
went cyclization to afford the pyrrolidinone 259, which could be
converted into all members of the family.
In Tambar's asymmetric synthesis of amanthaspiramide F,
proline derivative 260 underwent a palladium-catalyzed allylic
substitution of carbonate 261 to yield an intermediary quar-
ternary ammonium ion 262, which, aer deprotonation,
engaged in a stereoselective [2,3] Stevens rearrangement via 263
(Scheme 57a).395 The resulting ATA-containing pyrrolidine 264
was converted into amathaspiramide F.
More recently, Lee used a formal [3+2] cycloaddition
between lithium(trimethylsilyl)diazomethane 266 and a,b-
unsaturated ester 265 to set the ATA in amanthaspiramide CFig. 13 The amathaspiramides A–F.
514 | Nat. Prod. Rep., 2016, 33, 491–522(via intermediate 267, Scheme 57b).396 The N,N-bond in pyr-
azoline 268 was cleaved by treatment with p-TsOH and addi-
tional transformations led to the total synthesis of
amathaspiramide C and the formal synthesis of all the other
amathaspiramides.Scheme 57 Syntheses of amathaspiramides by Tambar (2013) and Lee
(2015). t-Bu ¼ tert-butyl, dba ¼ dibenzylideneacetone, MOM ¼
methoxymethyl, TMS ¼ trimethylsilyl.
This journal is © The Royal Society of Chemistry 2016
























































































View Article Online16 Conclusions
Herein, we have provided a survey of syntheses that feature the
installation of an a-tertiary amine (ATA) as a common thread.
This structural motif is widespread amongst alkaloids and has
physicochemical consequences, such as increased lipophilicity
and chromatographic mobility that distinguishes its bearers
from other basic amines. Since ATAs also occur in drug candi-
dates and building blocks for functional materials, our review is
intended to provide a useful reference for medicinal chemists
and colleagues active in the material sciences. It may also
provide a baseline for the development of additional and
hopefully more efficient methods for the synthesis of target
molecules containing a-tertiary amines.
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292 G. A. Molander and M. Rönn, J. Org. Chem., 1999, 64, 5183–
5187.
293 T. Arai, H. Abe, S. Aoyagi and C. Kibayashi, Tetrahedron
Lett., 2004, 45, 5921–5924.
294 G. Pandey and V. Janakiram, Chem.–Eur. J., 2015, 21,
13120–13126.
295 G. Lapointe, K. Schenk and P. Renaud, Org. Lett., 2011, 13,
4774–4777.
296 G. Scheffler, H. Seike and E. J. Sorensen, Angew. Chem., Int.
Ed., 2000, 39, 4593–4596.
297 M. Ousmer, N. A. Braun andM. A. Ciufolini,Org. Lett., 2001,
3, 765–767.
298 A.-J. Ma, Y.-Q. Tu, J.-B. Peng, Q.-Y. Dou, S.-H. Hou,
F.-M. Zhang and S.-H. Wang, Org. Lett., 2012, 14, 3604–
3607.
299 S. Ieda, T. Kan and T. Fukuyama, Tetrahedron Lett., 2010,
51, 4027–4029.
300 H.-H. Huo, H.-K. Zhang, X.-E. Xia and P.-Q. Huang, Org.
Lett., 2012, 14, 4834–4837.
301 H.-H. Huo, X.-E. Xia, H.-K. Zhang and P.-Q. Huang, J. Org.
Chem., 2013, 78, 455–465.
302 K. M. Brummond and J. L. Lu, Org. Lett., 2001, 3, 1347–
1349.
303 K. M. Brummond and S.-P. Hong, J. Org. Chem., 2005, 70,
907–916.
304 M. Movassaghi, M. Tjandra and J. Qi, J. Am. Chem. Soc.,
2009, 131, 9648–9650.
305 D. A. Evans, D. J. Adams and E. E. Kwan, J. Am. Chem. Soc.,
2012, 134, 8162–8170.
306 M. Kuramoto, C. Tong, K. Yamada, T. Chiba, Y. Hayashi
and D. Uemura, Tetrahedron Lett., 1996, 37, 3867–3870.
307 T. Chou, M. Kuramoto, Y. Otani, M. Shikano, K. Yazawa
and D. Uemura, Tetrahedron Lett., 1996, 37, 3871–3874.
308 J. Kobayashi and M. Ishibashi, Chem. Rev., 1993, 93, 1753–
1769.
309 D. Trauner, J. B. Schwarz and S. J. Danishefsky, Angew.
Chem., Int. Ed., 1999, 38, 3542–3545.
310 M. W. Carson, G. Kim and S. J. Danishefsky, Angew. Chem.,
Int. Ed., 2001, 40, 4453–4456.
311 M. W. Carson, G. Kim, M. F. Hentemann, D. Trauner and
S. J. Danishefsky, Angew. Chem., Int. Ed., 2001, 40, 4450–
4452.
312 H. S. Christie and C. H. Heathcock, Proc. Natl. Acad. Sci. U.
S. A., 2004, 101, 12079–12084.
313 S. Xu, H. Arimoto and D. Uemura, Angew. Chem., Int. Ed.,
2007, 46, 5746–5749.
314 S. Omura, K. Matsuzaki, T. Fujimoto, K. Kosuge, T. Furuya,
S. Fujita and A. Nakagawa, J. Antibiot., 1991, 44, 117–118.
315 S. Omura, T. Fujimoto, K. Otoguro, K. Matsuzaki,
R. Moriguchi, H. Tanaka and Y. Sasaki, J. Antibiot., 1991,
44, 113–116.This journal is © The Royal Society of Chemistry 2016
























































































View Article Online316 R. H. Feling, G. O. Buchanan, T. J. Mincer, C. A. Kauffman,
P. R. Jensen and W. Fenical, Angew. Chem., Int. Ed., 2003,
42, 355–357.
317 M. Shibasaki, M. Kanai and N. Fukuda, Chem.–Asian J.,
2007, 2, 20–38.
318 E. J. Corey and G. A. Reichard, J. Am. Chem. Soc., 1992, 114,
10677–10678.
319 E. J. Corey and G. A. Reichard, Tetrahedron Lett., 1993, 34,
6973–6976.
320 E. J. Corey and S. Choi, Tetrahedron Lett., 1993, 34, 6969–
6972.
321 T. Sunazuka, T. Nagamitsu, K. Matsuzaki, H. Tanaka,
S. Omura and A. B. Smith, J. Am. Chem. Soc., 1993, 115,
5302.
322 H. Uno, J. E. Baldwin and A. T. Russell, J. Am. Chem. Soc.,
1994, 116, 2139–2140.
323 N. Chida, J. Takeoka, N. Tsutsumi and S. Ogawa, J. Chem.
Soc., Chem. Commun., 1995, 793–794.
324 T. Nagamitsu, T. Sunazuka, H. Tanaka, S. Ōmura,
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